Anoro Ellipta (umeclidinium/vilanterol) is a brand-name inhaler that’s prescribed for chronic obstructive pulmonary disease (COPD). As with other drugs, Anoro ...
Anoro Ellipta is a brand-name prescription medication to manage chronic obstructive pulmonary disease (COPD) symptoms in adults. Common side effects of Anoro Ellipta are generally mild, but serious ...
Umeclidinium 62.5mcg, vilanterol 25mcg; per inhalation; dry pwd for oral inhalation. LABA as monotherapy (without ICS) for asthma can increase risk of asthma-related events. Do not initiate in ...
WASHINGTON, Sept 10 (Reuters) - A federal advisory panel recommended approval of GlaxoSmithKline Plc's new drug to treat chronic obstructive pulmonary disease(COPD ...
Anoro Ellipta is a brand-name inhaler that’s prescribed for long-term chronic obstructive pulmonary disease (COPD) treatment. Anoro Ellipta contains the active ingredients vilanterol and umeclidinium.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results